KRT31
protein-codingkeratin 31, the group of Keratins, type I
Gene summary
The protein encoded by this gene is a member of the keratin gene family. As a type I hair keratin, it is an acidic protein which heterodimerizes with type II keratins to form hair and nails. The type I hair keratins are clustered in a region of chromosome 17q12-q21 and have the same direction of transcription. [provided by RefSeq, Jul 2008]
- KRTHA1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KRT31 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002277.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 1 | 3 | |||
| missense | 53 | 3 | 56 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 53 | 5 | 1 | 59 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002268.2 | 7 | MANE Select | |
| Ensembl | ENSP00000251645.2 | 7 | MANE Select | |
| Ensembl | ENSP00000802573.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Estrogen signaling pathway - Homo sapiens (human)
- Keratinization
- Developmental Biology
Biological Process
- cytoskeleton organization
- epidermis development
- keratinization
- cornification
Molecular Function
- structural constituent of cytoskeleton
- protein binding
Cellular Component
- extracellular space
- cytosol
- intermediate filament
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000251645
- Coding exons
- 7
- Length
- 3869
- Individuals with no LoFs
- 121375
- Homozygous LoFs
- 70
- Heterozygous LoFs
- 4303
- Defined
- 125748
- p
- 0.0175
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.186 | 271 | 263 | 1.03 | 0.0000181 | 2707 |
| Missense (PolyPhen) | 94 | 95.021 | 0.98926 | 1047 | ||
| Synonymous | -1.34 | 134 | 116 | 1.16 | 0.00000765 | 843 |
| Loss of Function | 2.61 | 7 | 19.4 | 0.361 | 9.20e-7 | 209 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0050 | 0.0050 | notable |
| Latino/Admixed American | 0.0076 | 0.0075 | notable |
| Ashkenazi Jewish | 0.030 | 0.030 | notable |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.0074 | 0.0074 | notable |
| European (Non-Finnish) | 0.028 | 0.028 | notable |
| South Asian | 0.0094 | 0.0093 | notable |
| Other | 0.017 | 0.017 | notable |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.209
Intolerance Scores
- LoFtool
- 0.142
- RVIS EVS
- 0.16
- RVIS percentile EVS
- 64.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.794
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |